MedTrace Logo

The Australian HCV Point-of-Care Testing Program

NCT05042544 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60000

Last updated 2026-03-31

No results posted yet for this study

Summary

The National Australian HCV Point-of-Care Testing Program will establish an observational cohort to evaluate whether scale-up of finger-stick point-of-care HCV testing increases diagnosis and treatment for HCV infection. Participants will be recruited from settings providing services to people with a risk factor for the acquisition of HCV infection (including drug treatment clinics, needle and syringe programs, homelessness settings, mental health services, prisons, and mobile outreach). Participants will attend a single visit to have their HCV RNA status tested and complete a self-administered survey. Participants will not receive treatment as a part of this study. Participants who are HCV RNA positive will be linked to standard of care.

Conditions

  • Hepatitis C

Interventions

DIAGNOSTIC_TEST

Point-of-Care Testing

Participants will be offered finger-stick point-of-care testing for HCV

Sponsors & Collaborators

  • Flinders University

    collaborator OTHER

  • Kirby Institute

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-22
Primary Completion
2029-06-30
Completion
2029-06-30

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05042544 on ClinicalTrials.gov